| Viatris Pharma GmbH - Influvac 0.5 ml, Injektionssuspension in einer Fertigspritze | | 69992 | | 02 | | Influvac 0.5 ml | | Injektionssuspension in einer Fertigspritze | | J07BB02 | | Influenza, Inactivated, Split Virus Or Surface Antigen | | 13.08.2026 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) (Virus-Stamm A/Missouri/11/2025 (H1N1)-pdm09: reassortant virus IVR-279 derived from A/Missouri/11/2025) 15 µg, haemagglutininum influenzae A (H3N2) (Virus-Stamm A/Darwin/1454/2025 (H3N2)-like: reassortant virus SAN-049A derived from A/Michigan/105/2025) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Tokyo/EIS13-175/2025-like: reassortant virus derived from B/Tokyo/EIS13-175/2025 (Victoria lineage),wild type) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 2 mg, kalium 0.08 mg, residui: natrii citras dihydricus, saccharum, cetrimidum, formaldehydum, gentamicini sulfas, tylosini tartras, hydrocortisonum, polysorbatum 80, ovalbuminum. | | Packungsbestandteile | | | | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | | | | B | | No | | 004 | 10 | | | B | | No |
|
|
